Normalizing hepcidin predicts TMPRSS6 mutation status in patients with chronic iron deficiency

Blood. 2018 Jul 26;132(4):448-452. doi: 10.1182/blood-2017-03-773028. Epub 2018 Jun 12.

Matthew M Heeney^{1

2

3}, Dongjing Guo³, Luigia De Falco^{4

5}, Dean R Campagna⁶, Gordana Olbina⁷, Paige P-C Kao³, Klaus Schmitz-Abe⁸, Fedik Rahimov⁹, Patrick Gutschow⁷, Keith Westerman⁷, Vaughn Ostland⁷, Tracy Jackson¹⁰, Robert J Klaassen¹⁰, Kyriacos Markianos⁶, Karin E Finberg¹¹, Achille Iolascon^{4

5}, Mark Westerman⁷, Wendy B London^{1

2

3}, Mark D Fleming⁶

¹ Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA.
² Dana-Farber Cancer Institute, Boston, MA.
³ Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA.
⁴ Department of Molecular Medicine and Medical Biotechnologies, Federico II University Medical School, Naples, Italy.
⁵ CEINGE Biotecnologie Avanzate, Naples, Italy.
⁶ Department of Pathology, Boston Children's Hospital, Boston, MA.
⁷ Intrinsic LifeSciences, La Jolla, CA.
⁸ Division of Newborn Medicine, and.
⁹ Division of Genetics and Genomics, Department of Medicine, Boston Children's Hospital, Boston, MA.
¹⁰ Division of Pediatric Hematology-Oncology, Children's Hospital of Eastern Ontario, Ottawa, ON, Canada; and.
¹¹ Department of Pathology, Yale University, New Haven, CT.

No abstract available

Publication types